Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: Post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials
- 31 December 2005
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 27 (12), 1901-1911
- https://doi.org/10.1016/j.clinthera.2005.12.013
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Severity of depressive episodes according to ICD-10: prediction of risk of relapse and suicideThe British Journal of Psychiatry, 2004
- Cognitive deficits are associated with functional impairment in severely depressed patientsPsychiatry Research, 2003
- Levels of disability in Major Depression: Findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)Journal of Affective Disorders, 2003
- The Epidemiology of Major Depressive DisorderJama-Journal Of The American Medical Association, 2003
- Severe DepressionCNS Drugs, 2001
- Suicidal Ideation in Major Depression: Sex Differences and Impact of Comorbid AnxietyThe Canadian Journal of Psychiatry, 2000
- Prevalence of and Risk Factors for Lifetime Suicide Attempts in the National Comorbidity SurveyArchives of General Psychiatry, 1999
- Risk Factors for Sustained Nonremission of Depressive SymptomsJournal of Nervous & Mental Disease, 1998
- Suicide and AntidepressantsDrugs, 1992
- Clinical predictors of suicide in patients with major affective disorders: a controlled prospective studyAmerican Journal of Psychiatry, 1987